Reverse phase protein array: Validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

Molecular Cancer Therapeutics

Volumn 5, Issue 10, 2006, Pages 2512-2521

  Tibes, Raoul ^a   Qiu, Yi Hua ^a   Lu, Yiling ^a   Hennessy, Bryan ^a   Andreeff, Michael ^a   Mills, Gordon B ^a   Kornblau, Steven M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BIOTECHNOLOGY; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; FREEZE THAWING; GENE ACTIVATION; GENE AMPLIFICATION; HEMATOPOIETIC STEM CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; RELIABILITY; REPRODUCIBILITY; SAMPLING; SIGNAL TRANSDUCTION; STAINING; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; PROSPECTIVE STUDIES; PROTEIN ARRAY ANALYSIS; PROTEOME; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33750456480     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-06-0334     Document Type: Article

References (23)

1. Lian Z, Wang L, Yamaga S, et al. Genomic and proteomic analysis of the myeloid differentiation program. Blood 2001;98:513-24.
2. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19:1720-30.
3. Diks SH, Peppelenbosch MP. Single cell proteomics for personalised medicine. Trends Mol Mad 2004;10:574-7.
4. Cui JW, Wang J, He K, et al. Proteomic analysis of human acute leukemia cells: insight into their classification. Clin Cancer Res 2004;10: 6887-96.
5. Juan HF, Lin JY, Chang WH, et al. Biomic study of human myeloid leukemia cells differentiation to macrophages using DNA array, proteomic, and bioinformatic analytical methods. Electrophoresis 2002;23: 2490-504.
6. Wan J, Wang J, Chang H, et al. Proteomic analysis of apoptosis initiation induced by all-trans retinoic acid in human acute promyelocytic leukemia cells. Electrophoresis 2001;22:3026-37.
7. Ota J, Yamashita Y, Okawa K, et al. Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders. Oncogene 2003;22:5720-8.
8. Charboneau L, Scott H, Chen T, et al. Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays. Brief Funct Genomic Proteomic 2002; 1:305-15.
9. Nishizuka S, Charboneau L, Young L, et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A 2003;100:14229-34.
10. Paweletz CP, Charboneau L, Bichsel VE, et al. Reverse phase protein microarrays which capture disease progression show activation of prosurvival pathways at the cancer invasion front. Oncogene 2001;20: 1981-9.
11. Wulfkuhle JD, Aquino JA, Calvert VS, et al. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 2003;3:2085-90.
12. Grubb RL, Calvert VS, Wulkuhle JD, et al. Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 2003;3: 2142-6.
13. Zha H, Raffeld M, Charboneau L, et al. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab Invest 2004;8:235-44.
14. Kornblau SM, Womble M, Cade JS, Lemker EM, Qiu YH. Comparative analysis of the effects of sample source and test methodology on the assessment of protein expression in acute myelogenous leukemia. Leukemia 2005;19:1550-7.
15. Konopleva M, Zhao S, Hu W, et al. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of nonproliferating leukaemic CD34+ cells. Br J Haematol 2002;118:521-34.
16. Kornblau SM, Xu H-J, Zhang W, et al. Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood 1994;84:256-61.
17. Kornblau SM, Vu HT, Ruvolo P, et al. BAX and PKCα modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia. Clin Cancer Res 2000;6:1401-9.
18. Espina V, Mehta Al, Winters ME, et al. Protein microarrays: molecular profiling technologies for clinical specimens. Proteomics 2003; 3:2091-100.
19. Hunyady B, Krempels K, Harta G, Mezey E. Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J Histochem Cytochem 1996;44:1353-62.
20. Tibes R, Qui YH, Coombes KR, Gold D, Mills GB, Kornblau SM. Classification of acute myelogenous leukemia (AML) based on patterns of signal transduction pathway (STP) and apoptosis regulating protein activation determined by reverse phase proteins arrays (RPPA). Blood 2005;106:145a.
21. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-7.
22. Tibes R, Liu Y, Siwak D, Hennessy B, LaPushin R, Mills GB. Identification of selective inhibition of phospho-S6 ribosomal protein in XK469 sensitive leukemia cell lines using functional proteomic analysis. Proc Am Assoc Cancer Res 2005;46:772.
23. Xu O, Simpson SE, Scialla TJ, Bagg A, Carroll M. Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 2003;102: 972-80.